Our study found that CXCL16 was overexpressed in the AVC with MS patients; thus, we surmise that CXCL16 may induce CD8+ T-cell infiltration and ox-LDL metabolism, resulting in the AVC process. Here, CD8A is linked to myeloid sarcoma.